Barclays Keeps Their Buy Rating on Progyny (PGNY)
Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period
Fairway Independent Mortgage Corporation Offers Comprehensive Fertility Benefits
MADISON, Wis., April 22, 2024 /PRNewswire/ -- Fairway Independent Mortgage Corporation, named #1 for customer satisfaction among mortgage origination companies in the J.D. Power 2023 U.S. Mortgage Or
Truist Securities Reiterates Buy on Progyny, Maintains $46 Price Target
Truist Securities analyst Jailendra Singh reiterates Progyny with a Buy and maintains $46 price target.
Progyny Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/17/2024 38.53% Truist Securities $46 → $46 Reiterates Buy → Buy 02/28/2024 44.56% Cantor Fitzgerald → $
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)
Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024
Jim Cramer Recommends Five Small-cap Health-care Stocks
CNBC's Jim Cramer said he thinks it could be a good year for small-cap health stocks and shared his top health-care picks. "I think 2024 could ultimately be the year that small-cap stocks get their mojo back," he said. "This is a group that went out of style when interest rates soared and they'll work a lot better as rates come down."
With Progyny, Inc. (NASDAQ:PGNY) It Looks Like You'll Get What You Pay For
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider Progyny, Inc. (NASDAQ:PGNY) as a stock to avoid entirely with its 55.2x P/E
Progyny and RESOLVE to Honor National Infertility Awareness Week With Events Spanning Coast to Coast
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challengesNEW Y
Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
Progyny(PGNY.US) Officer Sells US$240.45K in Common Stock
$Progyny(PGNY.US)$ Officer Sturmer Michael E sold 6,395 shares of Common Stock on Apr 1, 2024 at an average price of $37.6 for a total value of $240.45K.Source: Announcement What is statement of chang
Truist Financial Sticks to Its Buy Rating for Progyny (PGNY)
Form 144 | Progyny(PGNY.US) Officer Proposes to Sell 240.45K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Progyny(PGNY.US)$ Officer Sturmer Michael E intends to sell 6,395 shares of its common stock on Apr 1, with a total market value of approximately $240.45K. Sturmer Mi
Form 144 | Progyny(PGNY.US) Officer Proposes to Sell 419.98K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Progyny(PGNY.US)$ Officer Livingston Mark S. intends to sell 11,165 shares of its common stock on Apr 1, with a total market value of approximately $419.98K. Livingst
Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)
Progyny(PGNY.US) Officer Sells US$2.69 Million in Common Stock
$Progyny(PGNY.US)$ Officer Schlanger David J sold 71,272 shares of Common Stock on Mar 27, 2024 at an average price of $37.8026 for a total value of $2.69 million.Source: Announcement What is statemen
Insiders Are Dumping These 10 Healthcare Stocks
Executive Chairman David Schlanger Sells Shares of Progyny Inc (PGNY)
Progyny(PGNY.US) Officer Sells US$109.22K in Common Stock
$Progyny(PGNY.US)$ Officer Schlanger David J sold 2,902 shares of Common Stock on Mar 25, 26, 2024 at an average price of $37.635 for a total value of $109.22K.Source: Announcement What is statement o
No Data